AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

IBUPROFEN 400.000 Mg ;

11 registrations across 1 African market— 11 active

Markets with IBUPROFEN 400.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
PROFUSOL 400 mg
Soft Gelatin Capsule
🇪🇬EgyptEuropean egyptian pharmaceutical industriesactive
Megafen N 400 mg / 4 ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
IBUPROFEN 400 mg USP 30
Tablets
🇪🇬EgyptAlfacure Pharmaceuticalsactive
IBUPROFEN 400mg
Tablets
🇪🇬EgyptThe Arab company for gelatin and pharmaceutical products (Arab Caps)active
IBUPROFEN 400mg
Tablets
🇪🇬EgyptThe Arab company for gelatin and pharmaceutical products (Arab Caps)active
Megafen N 400 mg / 4 ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
IBUPROFEN 400 mg USP 30
Tablets
🇪🇬EgyptAlfacure Pharmaceuticalsactive
Nova-Profen 400 mg
Film Coated Tablets
🇪🇬EgyptSanofi Egyptactive
IBUFEN 400 mg
Tablets
🇪🇬EgyptMEMPHIS for pharmaceuticals and chemical industriesactive
Nova-Profen 400 mg
Film Coated Tablets
🇪🇬EgyptSanofi Egyptactive
IBUFEN 400 mg
Tablets
🇪🇬EgyptMEMPHIS for pharmaceuticals and chemical industriesactive

IBUPROFEN 400.000 Mg ; in Africa — Regulatory Overview

IBUPROFEN 400.000 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.